© 2005 by BMJ Publishing Group & British Cardiac Society
JournalScan
| The first 150 words of the full text of this article appear below. |
ISCHAEMIC HEART DISEASE
N terminal pro-B-type natriuretic peptide (NT-proBNP) was measured in baseline serum samples from 1034 patients referred for angiography because of symptoms or signs of coronary heart disease. The rate of death from all causes was determined after a median follow up of nine years. At follow up, 288 patients had died. The median NT-proBNP concentration was significantly lower among patients who survived than among those who died (120 pg/ml, interquartile range (IQR) 50318 pg/ml, v 386 pg/ml, IQR 146897 pg/ml; p < 0.001). Patients with NT-proBNP concentrations in the highest quartile were older, had a lower left ventricular ejection fraction (LVEF) and a lower creatinine clearance rate, and were more likely to have a history of myocardial infarction, clinically significant coronary artery disease, and diabetes than patients with NT-proBNP concentrations in the lowest quartile. In a multivariable Cox regression model, the hazard ratio for death from any cause for the
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
